ArticleOncotarget2019

Neoadjuvant nimotuzumab plus chemoradiotherapy compared to neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for locally advanced esophageal squamous cell carcinoma.

Yongshun Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.